Published in Ann Surg on September 01, 1983
The orderly progression of melanoma nodal metastases. Ann Surg (1994) 2.16
Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg (1991) 2.06
Recent advances in the care of the patient with malignant melanoma. Ann Surg (1997) 1.92
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg (1994) 1.41
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg (1991) 1.27
Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg (1994) 1.16
Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg (1996) 1.09
Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator. Ann Surg (1985) 0.81
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg (1970) 12.72
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer (1978) 2.90
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Malignant melanoma of the upper extremities. J Surg Oncol (1981) 1.00
TREAT OR WATCH?AN EVALUATION OF ELECTIVE TREATMENT OF CLINICALLY UNINVOLVED NODES IN MALIGNANT MELANOMA. Med J Aust (1965) 0.90
Malignant melanoma of the trunk: a retrospective review of 1128 patients. Cancer (1982) 0.89
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med (1985) 5.82
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol (1986) 3.65
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood (1984) 3.65
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev (1993) 2.82
Actinomycin D: inhibition of respiration and glycolysis. Science (1966) 2.47
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res (1986) 2.37
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol (1989) 2.32
Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg (1990) 2.27
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol (1988) 2.06
Improved computer program data for the resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Anal Biochem (1974) 2.06
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
Resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Anal Biochem (1968) 2.02
Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res (1986) 2.01
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res (1989) 2.00
In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg (2000) 1.95
Metastatic melanoma in the thorax: report of 130 patients. AJR Am J Roentgenol (1981) 1.95
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol (1995) 1.94
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg (1995) 1.90
Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol (1998) 1.81
Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol (1985) 1.81
Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissue. Histopathology (2008) 1.80
Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab (1988) 1.78
A kinetic model for the sodium conductance system in squid axon. Biophys J (1976) 1.74
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery (1990) 1.72
Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol (1999) 1.68
Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am (1998) 1.67
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol (2001) 1.66
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg (1991) 1.61
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol (1991) 1.60
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch Surg (1994) 1.56
Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg (1988) 1.55
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer (1998) 1.54
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (1999) 1.50
The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol (1981) 1.49
Malignant melanoma and pregnancy. Cancer (1985) 1.47
The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol (1998) 1.47
Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer (1994) 1.46
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43
Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med (1980) 1.43
Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol (1995) 1.42
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg (1994) 1.41
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst (1993) 1.40
Sinus histiocytosis with massive lymphadenopathy. Case report and review of a multisystemic disease with cutaneous infiltrates. J Am Acad Dermatol (1988) 1.39
Intercellular junctions and tumor behavior in lung cancer. Mod Pathol (1991) 1.38
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res (1994) 1.38
Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol (1998) 1.38
Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol (2000) 1.38
Chloroma (granulocytic sarcoma) without evidence of leukemia: facilitated light microscopic diagnosis. Blood (1980) 1.37
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. Mod Pathol (1997) 1.32
Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol (1989) 1.32
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
Skin graft rejection between subjects genotyped for HL-A. Transplant Proc (1969) 1.29
Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (1992) 1.28
Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg (2001) 1.28
Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery (1998) 1.28
Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg (1991) 1.27
Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery (2001) 1.26
Positron emission tomography scanning in malignant melanoma. Cancer (2000) 1.25
Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg (1978) 1.25
Thymolipoma in association with myasthenia gravis. Arch Pathol Lab Med (1978) 1.24
The ratio of prostate chips with cancer: a new measure of tumor extent and its relationship to grade and prognosis. Hum Pathol (1988) 1.23
Prostate cancer and chip specimens: complete versus partial sampling. Hum Pathol (1986) 1.23
Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg (1984) 1.23
Central nervous system metastases in malignant melanoma. Neurosurgery (1981) 1.21
Renal cell carcinoma with rhabdoid features. Am J Surg Pathol (2000) 1.20
Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am J Pathol (1979) 1.19